- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04266184
Effects of Pelvic Belt and Kinesio Tape on Pain and Functional Mobility in Pregnancy-Related Pelvic Girdle Pain
Gebeliğe Bağlı Pelvik Kuşak Ağrısında Pelvik Kemer ve Kinezyo Bant Uygulamalarının Ağrı ve Fonksiyonel Mobilite Üzerine Etkileri
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: İlkim Çıtak Karakaya
- Phone Number: 05323611451
- Email: ilkim74@yahoo.com
Study Contact Backup
- Name: Dilan Aydemir
- Phone Number: +905372199221
- Email: dilanaydemir_@hotmail.com
Study Locations
-
-
-
Istanbul, Turkey
- Recruiting
- Bezmialem Vakıf University
-
Contact:
- Dilan Aydemir
- Phone Number: +905372199221
- Email: dilanaydemir_@hotmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- being able to read and write in Turkish
- being in 2nd or 3rd trimester of pregnancy
- having PGP for more than one week
- signing the informed consent form for the study
Exclusion Criteria:
- visual, auditory or cognitive problems which may prevent participation to the study
- health problems other than pregnancy-related PGP (orthopedic, neurologic, cardiorespiratory, etc.) or trauma history, which may affect standing from sitting, walking or stair climbing activities
- any gynecological or urological problems which may mimic pregnancy related PGP
- any diagnosed pregnancy complications other than PGP (preeclampsy, hypertension, diabetes,placental/fetal anomaly, preterm labor, etc.)
- high risk pregnancy (multiple gestation, etc.)
- history of spinal injury, ankylosing spondilitis, rheumatoid arthritis, intervertebral disc pathology)
- A positive straight leg raise test result, as well as sensory or motor deficits indicating intervertebral disc pathology
- history of prepregnancy low back or pelvic girdle pain
- using any analgesic or myorelaxant medication
- contraindications to KT or PB (impaired skin integrity or lesion in the lumbopelvic and abdominal regions, history of allergic reaction, etc.)
- previous KT (abdominal or lumbosacral) or PB experience
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Kinesio tape (KT)
Abdominal and symphisis pubis supported lumbopelvic KT will be applied.
This group will also receive the same educational program with the control group.
|
For abdominal taping, four I-shaped tapes will be used. Two of them will start from the superior symphisis pubis, follow the rectus abdominis muscle, and finish at the xiphoid process. Other two I-shaped tapes will start from the mid-symphisis pubis, follow the external oblique abdominals, and finish at the spina iliaca anterior superiors. Symphisis pubis taping will be applied with two I-shaped tapes, by forming a "X" shape. For lumbopelvic taping, three I-shaped KTs will be used. Two tapes will be applied bilaterally and longitudinally on the lumbar erector spinal muscles. The third tape will start from one sacroiliac joint and end at the other, vertically to the previous two tapes, forming a H-shape. All tapings will be applied with 15-25% tension (tape-off tension). KTs will stay three days. They will be removed from the site, and the skin will be checked and cleaned. Then, they will be reapplied for the next three days.
Other Names:
This program will include pain neuroscience education and ergonomic education, and will approximately last one hour.
|
Active Comparator: Pelvic belt (PB)
A narrow and flexible adjustable pelvic belt will be used in high position (just under the spina iliaca anterior superior).
This group will also receive the same educational program with the control group.
|
This program will include pain neuroscience education and ergonomic education, and will approximately last one hour.
The women in this group will use the belts, after adjusting them at a comfortable tension, after getting up the bed in the mornings, during daily activities and walking.
Evaluation will be made three days after the first application and they will be asked to continue using it for the second three-day period.
Other Names:
|
Other: Control group
This group will receive a 1-hour educational program composed of neuroscience education and ergonomic training.
|
This program will include pain neuroscience education and ergonomic education, and will approximately last one hour.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
change in general pain intensity during activity
Time Frame: baseline, approximately one-hour after the first intervention, three days after the first intervention, one week after the first intervention, and one week after cessation of intervention
|
The women will be asked to mark their pain intensity during activities in general.
0 (no pain)-10 cm (unbearable pain) visual analogue scale will be used.
|
baseline, approximately one-hour after the first intervention, three days after the first intervention, one week after the first intervention, and one week after cessation of intervention
|
change in pain intensity during five times sit to stand test
Time Frame: baseline, approximately one-hour after the first intervention, three days after the first intervention, one week after the first intervention, and one week after cessation of intervention
|
The women will be asked to mark their pain intensity during five times sit to stand test.
0 (no pain)-10 cm (unbearable pain) visual analogue scale will be used.
|
baseline, approximately one-hour after the first intervention, three days after the first intervention, one week after the first intervention, and one week after cessation of intervention
|
change in pain intensity during five-stairs climbing test
Time Frame: baseline, approximately one-hour after the first intervention, three days after the first intervention, one week after the first intervention, and one week after cessation of intervention
|
The women will be asked to mark their pain intensity during five-stairs climbing test.
0 (no pain)-10 cm (unbearable pain) visual analogue scale will be used.
|
baseline, approximately one-hour after the first intervention, three days after the first intervention, one week after the first intervention, and one week after cessation of intervention
|
change in pain intensity during timed up and go test
Time Frame: baseline, approximately one-hour after the first intervention, three days after the first intervention, one week after the first intervention, and one week after cessation of intervention
|
The women will be asked to mark their pain intensity during timed up and go test.
0 (no pain)-10 cm (unbearable pain) visual analogue scale will be used.
|
baseline, approximately one-hour after the first intervention, three days after the first intervention, one week after the first intervention, and one week after cessation of intervention
|
change in impairment during active straight leg raise test
Time Frame: baseline, approximately one-hour after the first intervention, three days after the first intervention, one week after the first intervention, and one week after cessation of intervention
|
The women will be asked to score their impairment during active straight leg raise test.
0 (not difficult at all)-5 (unable to do) scoring system will be used.
Scores for right and left legs will be summed and recorded.
|
baseline, approximately one-hour after the first intervention, three days after the first intervention, one week after the first intervention, and one week after cessation of intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
change in kinesiophobia
Time Frame: baseline, three days after the first intervention, one week after the first intervention, and one week after cessation of intervention
|
Turkish version of Tampa Kinesiophobia Scale will be used.
The score ranges between 17 and 68, and higher score indicates higher kinesiophobia.
|
baseline, three days after the first intervention, one week after the first intervention, and one week after cessation of intervention
|
change in activity limitation
Time Frame: baseline, three days after the first intervention, one week after the first intervention, and one week after cessation of intervention
|
Turkish version of Pelvic Girdle Questionnaire will be used.
Total score varies between 0 and 75, and higher score indicates higher activity limitation.
|
baseline, three days after the first intervention, one week after the first intervention, and one week after cessation of intervention
|
change in sleep quality
Time Frame: baseline, three days after the first intervention, one week after the first intervention, and one week after cessation of intervention
|
Quality of sleep will be assessed on a 0 (very bad)-10 (very good) cm VAS.
|
baseline, three days after the first intervention, one week after the first intervention, and one week after cessation of intervention
|
patient compliance
Time Frame: baseline, three days after the first intervention, one week after the first intervention, and one week after cessation of intervention
|
For PB and KT groups, comfort and easiness of using PB and KT will be assessed by 0 (not at all)-10 (extremely comfortable/easy) cm VASs.
All groups will be questioned about the comprehensibility of the educational program on 0 (not at all)-10 (completely comprehensible) cm VASs.
Also, degree of following the suggestions given in the educational program will be evaluated by 0 (not at all)-10 (completely) cm VASs.
|
baseline, three days after the first intervention, one week after the first intervention, and one week after cessation of intervention
|
treatment satisfaction
Time Frame: baseline, three days after the first intervention, one week after the first intervention, and one week after cessation of intervention
|
Treatment satisfaction will be assessed by 0 (not at all)-10 (extremely satisfactory) cm VASs.
|
baseline, three days after the first intervention, one week after the first intervention, and one week after cessation of intervention
|
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
General Publications
- Louw A, Diener I, Butler DS, Puentedura EJ. The effect of neuroscience education on pain, disability, anxiety, and stress in chronic musculoskeletal pain. Arch Phys Med Rehabil. 2011 Dec;92(12):2041-56. doi: 10.1016/j.apmr.2011.07.198.
- Bodes Pardo G, Lluch Girbes E, Roussel NA, Gallego Izquierdo T, Jimenez Penick V, Pecos Martin D. Pain Neurophysiology Education and Therapeutic Exercise for Patients With Chronic Low Back Pain: A Single-Blind Randomized Controlled Trial. Arch Phys Med Rehabil. 2018 Feb;99(2):338-347. doi: 10.1016/j.apmr.2017.10.016. Epub 2017 Nov 11.
- Draper C, Azad A, Littlewood D, Morgan C, Barker L, Weis CA. Taping protocol for two presentations of pregnancy-related back pain: a case series. J Can Chiropr Assoc. 2019 Aug;63(2):111-118.
- Bertuit J, Van Lint CE, Rooze M, Feipel V. Pregnancy and pelvic girdle pain: Analysis of pelvic belt on pain. J Clin Nurs. 2018 Jan;27(1-2):e129-e137. doi: 10.1111/jocn.13888. Epub 2017 Nov 3.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 47921137-050.01.04-E.144981
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pelvic Girdle Pain
-
Foundation University IslamabadActive, not recruitingPregnancy Related Pelvic Girdle PainPakistan
-
Helse Stavanger HFUniversity of StavangerCompletedPelvic Girdle Pain Post Partum | Low Back Pain Post PartumNorway
-
Muş Alparlan UniversityCompletedPregnancy-Related Pelvic Girdle PainTurkey
-
National Taiwan University Hospital Hsin-Chu BranchNational Taiwan University Hospital; National Taiwan UniversityRecruitingPelvic Girdle PainTaiwan
-
YI-JU TSAICompletedPelvic Girdle PainTaiwan
-
Loyola UniversityAmerican Academy of Physical Medicine and RehabilitationTerminatedPelvic Girdle PainUnited States
-
Centro Hospitalar Tondela-ViseuMarta Fernandes, M.D. MSc; Sonia Gonçalves, M.D; José Damasceno Costa, M.D.; Antonio... and other collaboratorsCompletedPelvic Girdle PainPortugal
-
Helse Stavanger HFUniversity of StavangerCompleted
-
Riphah International UniversityCompletedPelvic Girdle PainPakistan
-
Loyola UniversityCompletedPelvic Girdle PainUnited States
Clinical Trials on Kinesio tape (KT)
-
Cairo UniversityHeliopolis UniversityEnrolling by invitationShoulder Impingement SyndromeEgypt
-
University Rovira i VirgiliCompleted
-
Haydarpasa Numune Training and Research HospitalCompletedMyofascial Pain Syndrome | Myofascial Trigger Point PainTurkey
-
Norwegian School of Sport SciencesCompletedMuscle Weakness | Shoulder PainNorway
-
October 6 UniversityRecruitingDiastasis RectiEgypt
-
Paulista UniversityCompleted
-
Cairo UniversityCompletedPost Mastectomy Complications
-
University of Alabama at BirminghamRecruiting
-
Mayo ClinicCompleted
-
Paulista UniversityCompleted